Wednesday, December 2, 2020

Patients With Immune Disruption More Likely To Have Mental Health Disorders

A new study has found that patients with primary humoral immunodeficiency (PID), especially women, are 91% more likely to have mental health disorders and 84% more likely to exhibit suicidal behavior. Immune disruption could lead to recurrent infection, making people more vulnerable to autoimmune diseases.

“Show Rates” For Asthmatic Kids Increased During Pandemic – Thanks To Telemedicine

A new study has found that “show rates” for children with asthma increased during the ongoing coronavirus pandemic, as more and more parents seeking help through telemedicine. There has been a 32% to 62% increase in telemedicine visits during the COVID-19 pandemic.

Coronavirus Can Affect Cells and Tissues in the Mouth, Finds Study

A new study has found that the new coronavirus, aka SARS-CoV-2, affects the cells and tissues in the mouth, which is why most people experience loss of taste or smell. Loss of taste has been one of the characteristic symptoms of COVID-19. The study found saliva samples of patients containing the virus.

New AI Model Can Detect COVID Just By the Sound of Your Cough, Study

A new artificial intelligence (AI) model can detect asymptomatic cases of COVID-19 simply by the sound of people’s cough. The model has been found highly effective in preliminary studies, which can be used as a screening tool for COVID-19. The new AI model will be tested in humans after FDA’s permission.

Researchers Discover a Subset of COVID-19 Patients That Sustained Antivirus Antibodies

A team of researchers led by Dr. Duane Wesemann of Brigham and Women's Hospital has found a subset of COVID-10 patients who healed quickly and sustained coronavirus antibodies. The researchers found that people who recovered from mild to moderate infection developed long-lasting antibodies.

FDA Approves Sklice (Ivermectin) Lotion for OTC Use to Treat Head Lice

Arbor Pharmaceuticals received the FDA’s approval for Sklice (ivermectin) lotion as a nonprescription, or OTC, treatment for head lice. The FDA initially prepared Sklice as a prescription drug for head lice treatment in 2012. Recently, the FDA switched it to an OTC drug from a prescription drug.

Novel Vaccine May Halt the Progression of Alzheimer’s Disease

A new study, conducted on the mice, has shown that a novel vaccine, an antigen-presenting dendritic vaccine with a specific antibody response to oligomeric Aβ, could help halt the progression of Alzheimer’s disease. The study researchers said the vaccine could also help strengthen the immune system of older patients.